Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999

European Journal of Pediatrics

Volumn 160, Issue 9, 2001, Pages 541-547

  Berner, Reinhard ^a   Schwoerer, Florian ^a   Schumacher, Richard F ^b   Meder, Milan ^a   Forster, Johannes ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BRESCIA   (Italy)

^c St Josephskrankenhaus   (Germany)

Author keywords

Bronchiolitis; Bronchopulmonary dysplasia; Chronic lung disease; Prematurity; Respiratory syncytial virus

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILDHOOD MORTALITY; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; GERMANY; HIGH RISK POPULATION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFECTION RATE; INTENSIVE CARE; LOWER RESPIRATORY TRACT INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; PEDIATRIC HOSPITAL; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; SYNCYTIUM; VIRUS INFECTION;

CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; GERMANY; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0035724221     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310100801     Document Type: Article

References (31)

1. Prevention of respiratory syncytial virus infection: Indications for the use of palivizumab and update on the use of RSV-IVIG
2. International variation in the management of infants hospitalized with respiratory syncytial virus
3. Rehospitalization because of respiratory syncytial virus infections in premature infants younger than 33 weeks of gestation: A prospective study
4. Respiratory syncytial virus vaccines
5. The clinical picture presented by premature neonates infected with the respiratory syncytial virus
6. National surveillance for respiratory syncytial virus, United States
7. Viral pneumonia as a cause and result of hospitalization
8. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia
9. Nosocomial respiratory syncytial virus infections: The "Cold War" has not ended
10. Respiratory syncytial virus and influenza: Practical community surveillance
11. Development of local guidelines for prevention of respiratory syncytial viral infections
12. Respiratory syncytial and parainfluenza viruses
13. Nosocomial respiratory syncytial virus infections in a paediatric department
14. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody reduces hospitalization for respiratory syncytial virus infection in high-risk infants
15. Rehospitalization for respiratory syncytial virus among premature infants
16. Etiology of community-acquired pneumonia in 254 hospitalized children
17. Treatment and prevention of respiratory syncytial virus infection
18. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark
19. Respiratory syncytial viral infection in infants with congenital heart disease
20. Respiratory syncytial virus morbidity and mortality estimates in congenital heart patients: A recent experience
21. Improved outcome of respiratory syncytial virus infection in a high risk population of Canadian children
22. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex
23. Reduction of respiratory syncytial virus hospitalization among prematures infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
24. Advances in prevention of respiratory syncytial virus infections
25. Immunoprophylaxis of respiratory syncytial virus disease
26. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997
27. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7
28. Respiratory syncytial virus and premature infants born at 32 weeks of gestation or earlier: Hospitalization and economic implications of prophylaxis
29. Hospitalisation for RSV infection in ex-preterm infants - Implications for use of RSV immune globulin
30. Summertime respiratory syncytial virus infection: Epidemiology and clinical manifestations
31. Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany by multiplex reverse-transcriptase polymerase chain reaction